Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • KEYS vs GSK✓SelectedUSD · GSKKEYS vs GSK performance historyLatest closeAs of-4.05%11/16
Stock and ETF performance explorer

KEYS vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+48.2%
GSK return
+46.9%
Excess return
+1.3%
Maximum drawdown
-42.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-4.0%-0.1%-4.0%-4.0%
7D-1.2%-1.3%+0.2%-1.0%
30D-13.8%+2.7%-16.5%-14.1%
3M-20.2%+2.7%-22.9%-20.7%
6M-18.2%+3.3%-21.5%-19.2%
YTD+40.6%+6.5%+34.1%+37.5%
1Y+59.5%+10.7%+48.9%+54.6%
3Y+115.1%+64.4%+50.7%+85.0%
5Y+48.2%+46.7%+1.5%+18.7%
All+48.2%+46.9%+1.3%+18.7%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling